Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension

PURPOSE: To compare the diurnal intraocular pressure (IOP)-lowering efficacy and safety of travoprost 0.004% and tafluprost 0.0015% administered to patients with primary open-angle glaucoma or ocular hypertension. METHODS: This was a randomized, double-masked, active-controlled, crossover design tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnober, Dietmar, Hofmann, Günter, Maier, Hubert, Scherzer, Maria-Luise, Ogundele, Abayomi B, Jasek, Mark C
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009992/
https://www.ncbi.nlm.nih.gov/pubmed/21191441
http://dx.doi.org/10.2147/OPTH.S13720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009992/
https://www.ncbi.nlm.nih.gov/pubmed/21191441
http://dx.doi.org/10.2147/OPTH.S13720

Ejemplares similares